L1R3

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameL1R3
Drug Alias NameL1R3
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLymphoma, B-CellLeukemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCrucell NV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrucell NV
Active IndicationsN/A
Inactive IndicationsLymphoma, B-CellLeukemia

Other Information

ATC CodeN/A
Related LinksN/A